QIAGEN Enters Collaboration With Eli Lilly To Support Development Of QIAstat-Dx In-vitro Diagnostic To Detect APOE Genotypes Which Can Play Role In Diagnosis Of Alzheimer's Disease; No Terms Disclosed
QIAGEN Enters Collaboration With Eli Lilly To Support Development Of QIAstat-Dx In-vitro Diagnostic To Detect APOE Genotypes Which Can Play Role In Diagnosis Of Alzheimer's Disease; No Terms Disclosed
QIAGEN與Eli Lilly合作，支持QIAstat-Dx體外診斷試劑盒的開發，用於檢測可以在阿爾茨海默病診斷中發揮作用的APOE基因型；未透露條款。
This collaboration represents a significant milestone as the QIAstat-Dx panel would be the first commercially available IVD for APOE genotyping.
這次合作代表了一個重要的里程碑，因爲QIAstat-Dx面板將成爲首個用於APOE基因分型的商業化IVD產品。